scholarly journals Targeted Expression of Cyclin D2 Results in Cardiomyocyte DNA Synthesis and Infarct Regression in Transgenic Mice

2005 ◽  
Vol 96 (1) ◽  
pp. 110-118 ◽  
Author(s):  
Kishore B.S. Pasumarthi ◽  
Hidehiro Nakajima ◽  
Hisako O. Nakajima ◽  
Mark H. Soonpaa ◽  
Loren J. Field
2018 ◽  
Vol 115 (5) ◽  
pp. 960-965 ◽  
Author(s):  
Wuqiang Zhu ◽  
Sean Reuter ◽  
Loren J Field

Blood ◽  
2007 ◽  
Vol 110 (2) ◽  
pp. 743-751 ◽  
Author(s):  
Baochun Zhang ◽  
Zhe Wang ◽  
Tai Li ◽  
Erdyni N. Tsitsikov ◽  
Han-Fei Ding

Abstract The NF-κB2 gene is recurrently mutated in human lymphoid malignancies. However, a causal relationship between NF-κB2 mutation and lymphomagenesis has not been established. It is also unclear how the mutation may lead to lymphoid malignancies. We report the generation of transgenic mice with targeted expression of p80HT, a lymphoma-associated NF-κB2 mutant, in lymphocytes. The transgenic mice display a marked expansion of peripheral B cell populations and develop predominantly small B cell lymphomas. p80HT expression has no apparent effect on the proliferation of B cells, but renders them specifically resistant to apoptosis induced by cytokine deprivation and mitogenic stimulation. Lymphocytes and lymphoma cells from p80HT mice express high levels of TRAF1, an antiapoptotic protein also implicated in lymphoid malignancies. p80HT binds the TRAF1 promoter in vivo and activates TRAF1 transcription. Moreover, TRAF1 knockdown abrogates the antiapoptotic activity of p80HT and TRAF1 deficiency reestablishes B cell homeostasis in p80HT mice. These findings demonstrate NF-κB2 mutation as an oncogenic event in vivo and suggest a molecular pathway for TRAF1 activation in the pathogenesis of lymphomas.


PLoS ONE ◽  
2012 ◽  
Vol 7 (2) ◽  
pp. e29236 ◽  
Author(s):  
Cissy Chenyi Zhou ◽  
Jiang Chang ◽  
Tiejuan Mi ◽  
Shahrzad Abbasi ◽  
Dongmin Gu ◽  
...  

1992 ◽  
Vol 262 (2) ◽  
pp. C261-C275 ◽  
Author(s):  
A. P. Koretsky

Over the past 10 years significant progress has been made in techniques for manipulating the genome of the animal. Production of transgenic mice has led to important insights into the regulation of gene expression, the molecular basis of cancer, immunology, and developmental biology. The tools necessary to generate transgenic mice are becoming widely available, making it possible to study a variety of problems. In this review a description of the strategies being used to address problems of interest in cell physiology using transgenic mice is given. Elucidation of the rules governing the regulation of gene expression now permits the targeted expression of a protein to a particular organ or cell type within an organ. Overexpression of proteins, expression of foreign or mutant proteins, mislocalization of proteins, and directed elimination of proteins are all procedures that can now be used to generate interesting animal models for physiological studies. The applications of these techniques to a variety of problems in normal and abnormal physiology are discussed in this review.


1987 ◽  
Vol 3 ◽  
pp. 306-308 ◽  
Author(s):  
Bernd Groner ◽  
Cora-Ann Schönenberger ◽  
Anne Catherine Andres

2000 ◽  
Vol 275 (20) ◽  
pp. 15399-15406 ◽  
Author(s):  
Rupangi C. Vasavada ◽  
Adolfo Garcia-Ocaña ◽  
Walter S. Zawalich ◽  
Robert L. Sorenson ◽  
Pamela Dann ◽  
...  

2004 ◽  
Vol 280 (9) ◽  
pp. 8117-8124 ◽  
Author(s):  
John R. Harrison ◽  
Yu-Feng Huang ◽  
K. Amanda Wilson ◽  
Penny L. Kelly ◽  
Douglas J. Adams ◽  
...  

1993 ◽  
Vol 7 (7b) ◽  
pp. 1318-1324 ◽  
Author(s):  
S R Ross ◽  
R A Graves ◽  
B M Spiegelman

Sign in / Sign up

Export Citation Format

Share Document